Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEBRIKIZUMAB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

53.2%
Female
46.8%
Male

Age Information

The average age of patients reporting adverse events with LEBRIKIZUMAB is 49.2 years.

Geographic Distribution

The majority of adverse event reports for LEBRIKIZUMAB originate from ES.

Report Summary & Outcomes

78
Total Reports
78
As Primary/Secondary Suspect
1
Deaths Reported
27
Hospitalizations
1
Disabilities

Reporting Timeline

First adverse event report: 20000101. Most recent report: 20250801. View full timeline →

More About LEBRIKIZUMAB

LEBRIKIZUMAB Full Profile Reports by Year Drug Interactions